UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031694
Receipt number R000036192
Scientific Title Efficacy of luseogliflozin for fattty liver with diabetes mellitus
Date of disclosure of the study information 2018/04/01
Last modified on 2022/03/16 21:04:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of luseogliflozin for fattty liver with diabetes mellitus

Acronym

Efficacy of luseogliflozin for fattty liver with diabetes mellitus

Scientific Title

Efficacy of luseogliflozin for fattty liver with diabetes mellitus

Scientific Title:Acronym

Efficacy of luseogliflozin for fattty liver with diabetes mellitus

Region

Japan


Condition

Condition

fatty liver with type 2 diabetes mellitus

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To evaluate the effect of luseogliflozin for the patients with non-alcoholic fatty liver disease (NAFLD) complicated with type 2 diabetes mellitus.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

ALT

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Oral administration of 2.5mg luseogliflozin once a day for 24 weeks

Interventions/Control_2

Dietetic and exercise therapy

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

1. Provide written informed concent
2. Aged >=20, <75 at consent
3. Type 2 diabetes mellitus
4. Diagnosed NAFLD by imaging test
5. AST>=33 or ALT>=30 in males, ALT>=27 in females

Key exclusion criteria

1. Using insulin
2. Has hypersensitivity to luseogliflozin
3. Has history of hepatitis B, hepatitis C and autoimmune hepatitis
4. Excess alcohol consumption: 30g/day for males, 20g/day for females
5. Type 1 diabetes mellitus
6. HbA1c>9%
7. Has severe complication of diabetes
8. BMI<20
9. eGFR<45mL/min/1.73m2
10. Dialysis
11. Severe hepatic dysfunction and cirrhosis
12. Females who have a possibility of pregnancy or is pregnant
13. Has malignant neoplasm
14. After surgery and severe trauma
15. History of myocardinal infarction and angina pectoris
16. Had cerebral stroke, cerebral infanction, urinary infection or genital infection within 12 weeks before giving their consent
17. Using steroid and imunosuppressant
18. Using glimepiride>2mg/day, glibenclamide>1.25mg/day, gliclazide>40mg/day
19. Started other diabetic medicines or changed dose within 8 weeks before giving their consent
20. Using GLP-1 receptor agonist or SGLT2 inhibitors
21. In addition, when principal inverstigator or reseacher deems inappriate as a study subject

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Naoto
Middle name
Last name Kawabe

Organization

Fujita Health University

Division name

Department of Gastroenterology and Hepatology

Zip code

4701192

Address

1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, Japan

TEL

0562-93-2324

Email

kawabe@fujita-hu.ac.jp


Public contact

Name of contact person

1st name Naoto
Middle name
Last name Kawabe

Organization

Fujita Health University

Division name

Department of Gastroenterology and Hepatology

Zip code

4701192

Address

1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, Japan

TEL

0562-93-2324

Homepage URL


Email

kawabe@fujita-hu.ac.jp


Sponsor or person

Institute

Fujita Health University

Institute

Department

Personal name



Funding Source

Organization

Fujita Health University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fujita Health University IRB

Address

1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, Japan

Tel

0562-93-2865

Email

f-irb@fujita-hu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 04 Month 01 Day

Date of IRB

2018 Year 04 Month 10 Day

Anticipated trial start date

2018 Year 10 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 03 Month 12 Day

Last modified on

2022 Year 03 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036192


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name